Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
18 September 2020
Closing Date:
06 November 2020
Location(s):
DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
Description:
Conclusion of discount contracts in accordance with Section 130a (8) SGB V for pharmaceuticals in the generic market

The subject of the tender is the conclusion of discount agreements in accordance with Section 130a (8) SGB V for the period from June 1, 2021 to May 31, 2023 (AOK 1 - Future Location / Environment). The tender is based on the active ingredient for 5 professionals. Each active ingredient represents its own specialist lot. For each specialist lot, eight partial lots (territorial lots) are created as specified in the tender documents. The bidders decide for themselves which specialist lot (s) and which territorial lot (s) they want to submit discount offers for. Offers can only be submitted for one, for several or for all subject and area lots. The award is made for each subject and area lot. For each specialty and non-territorial lot combination, depending on the specialty, discount agreements are concluded with up to 3 pharmaceutical companies - provided there are sufficient offers that are eligible for a bid - up to 3 pharmaceutical companies.

Cefaclor

Reference is made to the brief description of the subject matter of the contract (see above) and in particular to the following:

Eight partial lots are created for the active substance in the tender, as follows:

- Arealess 1: AOK Bayern - Die Gesundheitskasse;

- Arealess 2: AOK - Die Gesundheitskasse in Hessen, AOK PLUS - Die Gesundheitskasse for Saxony and Thuringia;

- Arealess 3: AOK Baden-Württemberg;

- Area lot 4: AOK NordWest - Die Gesundheitskasse;

- Area lot 5: AOK Rheinland / Hamburg - Die Gesundheitskasse;

- Arealess 6: AOK Bremen / Bremerhaven, AOK - The health fund for Lower Saxony, AOK Saxony-Anhalt - The health fund;

- Area lot 7: AOK Nordost - Die Gesundheitskasse;

- Arealess 8: AOK Rhineland-Palatinate / Saarland - The health insurance company.

In addition, the more detailed information on the specialist in the tender documents applies.

Cefuroxime

Reference is made to the brief description of the subject matter of the contract (see above) and in particular to the following:

Eight partial lots are created for the active substance in the tender, as follows:

- Arealess 1: AOK Bayern - Die Gesundheitskasse;

- Arealess 2: AOK - Die Gesundheitskasse in Hessen, AOK PLUS - Die Gesundheitskasse for Saxony and Thuringia;

- Arealess 3: AOK Baden-Württemberg;

- Area lot 4: AOK NordWest - Die Gesundheitskasse;

- Area lot 5: AOK Rheinland / Hamburg - Die Gesundheitskasse;

- Arealess 6: AOK Bremen / Bremerhaven, AOK - Die Gesundheitskasse für Niedersachsen, AOK Sachsen-Anhalt - Die Gesundheitskasse;

- Area lot 7: AOK Nordost - Die Gesundheitskasse;

- Arealess 8: AOK Rhineland-Palatinate / Saarland - The health insurance company.

In addition, the more detailed information on the specialist in the tender documents applies.

Ciprofloxacin

Reference is made to the brief description of the subject matter of the contract (see above) and in particular to the following:

Eight partial lots are created for the active substance in the tender, as follows:

- Arealess 1: AOK Bayern - Die Gesundheitskasse;

- Arealess 2: AOK - Die Gesundheitskasse in Hessen, AOK PLUS - Die Gesundheitskasse for Saxony and Thuringia;

- Arealess 3: AOK Baden-Württemberg;

- Area lot 4: AOK NordWest - Die Gesundheitskasse;

- Area lot 5: AOK Rheinland / Hamburg - Die Gesundheitskasse;

- Arealess 6: AOK Bremen / Bremerhaven, AOK - Die Gesundheitskasse für Niedersachsen, AOK Sachsen-Anhalt - Die Gesundheitskasse;

- Area lot 7: AOK Nordost - Die Gesundheitskasse;

- Arealess 8: AOK Rhineland-Palatinate / Saarland - The health insurance company.

In addition, the more detailed information on the specialist in the tender documents applies.

Clarithromycin

Reference is made to the brief description of the subject matter of the contract (see above) and in particular to the following:

Eight partial lots are created for the active substance in the tender, as follows:

- Arealess 1: AOK Bayern - Die Gesundheitskasse;

- Arealess 2: AOK - Die Gesundheitskasse in Hessen, AOK PLUS - Die Gesundheitskasse for Saxony and Thuringia;

- Arealess 3: AOK Baden-Württemberg;

- Area lot 4: AOK NordWest - Die Gesundheitskasse;

- Area lot 5: AOK Rheinland / Hamburg - Die Gesundheitskasse;

- Arealess 6: AOK Bremen / Bremerhaven, AOK - Die Gesundheitskasse für Niedersachsen, AOK Sachsen-Anhalt - Die Gesundheitskasse;

- Area lot 7: AOK Nordost - Die Gesundheitskasse;

- Arealess 8: AOK Rhineland-Palatinate / Saarland - The health insurance company.

In addition, the more detailed information on the specialist in the tender documents applies.

Roxithromycin

Reference is made to the brief description of the subject matter of the contract (see above) and in particular to the following:

Eight partial lots are created for the active substance in the tender, as follows:

Arealess 1: AOK Bayern - Die Gesundheitskasse;

Arealess 2: AOK - The health insurance company in Hessen, AOK PLUS - The health insurance company for Saxony and Thuringia;

Arealess 3: AOK Baden-Württemberg;

Arealess 4: AOK NordWest - Die Gesundheitskasse;

Arealess 5: AOK Rheinland / Hamburg - Die Gesundheitskasse;

Arealess 6: AOK Bremen / Bremerhaven, AOK - The health fund for Lower Saxony, AOK Saxony-Anhalt - The health fund;

Area lot 7: AOK Nordost - Die Gesundheitskasse;

Arealess 8: AOK Rhineland-Palatinate / Saarland - The health insurance company.

In addition, the more detailed information on the specialist in the tender documents applies.

Download full details as .pdf
The Buyer:
AOK Baden-Württemberg
CPV Code(s):
33600000 - Pharmaceutical products